MARY BIJU: Open Payments
NPI 1942985114 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $95 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $107 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Alkermes, Inc. | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
Products named: INVEGA SUSTENNA, ABILIFY MAINTENA, ARISTADA, ABILIFY ASIMTUFII, UZEDY, FANAPT.
Industry payments across AZ — which companies pay providers there.
